Weinstein S P, O'Boyle E, Fisher M, Haber R S
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029.
Endocrinology. 1994 Aug;135(2):649-54. doi: 10.1210/endo.135.2.8033812.
The extent to which the glucose transport system in hepatocytes is regulated in states of altered hepatic glucose metabolism is unclear. Because thyroid hormone is known to increase hepatic glucose output, we hypothesized that thyroid hormone might up-regulate expression of the principal hepatic glucose transporter, GLUT2, facilitating increased glucose efflux across the hepatocyte plasma membrane. GLUT2 protein concentration in crude liver membranes was twice as high in chronically hyperthyroid vs. hypothyroid animals, with intermediate levels in euthyroid controls. Similar results were obtained for total GLUT2 protein, measured in detergent extracts of liver. Northern analysis of total liver RNA demonstrated parallel changes in GLUT2 messenger RNA (mRNA) concentration per g tissue (hypothyroid, 76 +/- 6%; euthyroid, 100 +/- 11%; hyperthyroid, 158 +/- 12%; data expressed as percentage of mean euthyroid values). The daily administration of a large dose of T3 (100 micrograms/100 g BW) to hypothyroid rats caused a prompt increase in hepatic GLUT2 mRNA concentration (2.5-fold at 1 day), but only a modest and gradual change in hepatic GLUT2 protein concentration (+40% at 4 days), suggesting that the GLUT2 protein in liver may have a long half-life. We conclude that thyroid hormone regulates hepatic GLUT2 mRNA and protein expression. Up-regulation of GLUT2 protein expression by thyroid hormone may serve to facilitate increased hepatic glucose output. These results suggest that the hepatic GLUT2 glucose transporter, like the enzymes of gluconeogenesis and glycolysis, is indeed a regulatory target for hormones that control hepatic glucose metabolism.
在肝脏葡萄糖代谢改变的状态下,肝细胞中葡萄糖转运系统的调节程度尚不清楚。由于已知甲状腺激素会增加肝脏葡萄糖输出,我们推测甲状腺激素可能会上调肝脏主要葡萄糖转运体GLUT2的表达,促进葡萄糖跨肝细胞质膜的流出增加。在慢性甲状腺功能亢进与甲状腺功能减退的动物中,粗制肝膜中的GLUT2蛋白浓度是后者的两倍,甲状腺功能正常的对照组则处于中间水平。在肝脏去污剂提取物中测得的总GLUT2蛋白也得到了类似结果。对肝脏总RNA的Northern分析表明,每克组织中GLUT2信使RNA(mRNA)浓度有平行变化(甲状腺功能减退,76±6%;甲状腺功能正常,100±11%;甲状腺功能亢进,158±12%;数据表示为甲状腺功能正常平均值的百分比)。每天给甲状腺功能减退的大鼠注射大剂量T3(100微克/100克体重)会导致肝脏GLUT2 mRNA浓度迅速增加(1天时增加2.5倍),但肝脏GLUT2蛋白浓度仅出现适度且逐渐的变化(4天时增加40%),这表明肝脏中的GLUT2蛋白可能具有较长的半衰期。我们得出结论,甲状腺激素调节肝脏GLUT2 mRNA和蛋白表达。甲状腺激素对GLUT2蛋白表达的上调可能有助于促进肝脏葡萄糖输出增加。这些结果表明,肝脏GLUT2葡萄糖转运体与糖异生和糖酵解酶一样,确实是控制肝脏葡萄糖代谢的激素的调节靶点。